Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | Europe | 2023

The global COVID-19 pandemic had a negative impact on European CRM procedure volumes and market growth in 2020; however, following a period of recovery, the European CRM device market will grow modestly through 2031. Growth in market revenue will be driven by increasing adoption of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs. However, increasing competition in the leadless pacemaker and S-ICD markets will put downward pressure on prices and consequently limit growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2031.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…